Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Ekaterina Pestova"'
Autor:
Martin J. van den Bent, Peter J. Ansell, Kyle D. Holen, Maria Guseva, Andrew M. Scott, Hui K. Gan, Priya Kumthekar, David Maag, Anahita Bhathena, Erica Gomez, Xin Lu, Zheng Zha, Carolyn Mullen, Rupinder Kular, Ekaterina Pestova, Minghao Song, Irina Sokolova, Lisa Roberts-Rapp, Andrew B. Lassman
Supplementary Table S1. Data for tumor samples and all assays performed.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45486a420e04d23f9dbed8bffb48dc5c
https://doi.org/10.1158/1078-0432.22469820.v1
https://doi.org/10.1158/1078-0432.22469820.v1
Autor:
Martin J. van den Bent, Peter J. Ansell, Kyle D. Holen, Maria Guseva, Andrew M. Scott, Hui K. Gan, Priya Kumthekar, David Maag, Anahita Bhathena, Erica Gomez, Xin Lu, Zheng Zha, Carolyn Mullen, Rupinder Kular, Ekaterina Pestova, Minghao Song, Irina Sokolova, Lisa Roberts-Rapp, Andrew B. Lassman
Purpose:Patients with glioblastoma (GBM) have a poor prognosis and are in desperate need of better therapies. As therapeutic decisions are increasingly guided by biomarkers, and EGFR abnormalities are common in GBM, thus representing a potential ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15671a97fee370559bbe15233ea8d7b6
https://doi.org/10.1158/1078-0432.c.6527364.v1
https://doi.org/10.1158/1078-0432.c.6527364.v1
Autor:
Martin J. van den Bent, Peter J. Ansell, Kyle D. Holen, Maria Guseva, Andrew M. Scott, Hui K. Gan, Priya Kumthekar, David Maag, Anahita Bhathena, Erica Gomez, Xin Lu, Zheng Zha, Carolyn Mullen, Rupinder Kular, Ekaterina Pestova, Minghao Song, Irina Sokolova, Lisa Roberts-Rapp, Andrew B. Lassman
Supplementary Table S2. Concordance of FISH and WES results. Supplementary Table S3. Point mutations identified in EGFR. Supplementary Table S4. Concordance of FISH and RT-PCR results. Supplementary Table S5. Concordance of FISH and RNAseq results. S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e1792b7fc7dba0544047eaf0284e3fa
https://doi.org/10.1158/1078-0432.22469823
https://doi.org/10.1158/1078-0432.22469823
Autor:
Lisa Roberts-Rapp, Andrew M. Scott, Kyle D. Holen, Ekaterina Pestova, David Maag, Rupinder Kular, Maria Guseva, Martin J. van den Bent, Erica Gomez, Hui K Gan, Andrew B. Lassman, Xin Lu, Minghao Song, Zheng Zha, Carolyn Mullen, Anahita Bhathena, Peter Ansell, Sokolova Irina A, Priya Kumthekar
Publikováno v:
Clinical Cancer Research, 25(11), 3259-3265. American Association for Cancer Research Inc.
Clin Cancer Res
Clin Cancer Res
Purpose: Patients with glioblastoma (GBM) have a poor prognosis and are in desperate need of better therapies. As therapeutic decisions are increasingly guided by biomarkers, and EGFR abnormalities are common in GBM, thus representing a potential the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38b3c9b47bba580c418ec020f665cd88
https://pure.eur.nl/en/publications/1b0ff6e9-0fa6-4c8e-8e30-2cef2a3a3eaa
https://pure.eur.nl/en/publications/1b0ff6e9-0fa6-4c8e-8e30-2cef2a3a3eaa
Autor:
Minghao Song, Jeffrey Panella, Olga Kornfeld, Thomas Perez, Hina Amin, Frank Policht, Ekaterina Pestova, Irina A. Sokolova
Glioblastoma (GBM) is the most common malignant brain tumor among adults with poor prognosis. Epidermal Growth Factor Receptor (EGFR) gene is found to be amplified in approximately 50% of GBM tumors. Drugs that target amplified EGFR are being evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb87be786c211d9208357496420555cf
https://europepmc.org/articles/PMC5691968/
https://europepmc.org/articles/PMC5691968/
Autor:
Sun Min Lim, Thomas Perez, Yoon Jin Cha, Shile Liang, Gu Li, Hye Ryun Kim, Yan Chin Tai, Won Young Park, Hyo Sup Shim, Ekaterina Pestova, Byoung Chul Cho, Frank Policht, Hyun Chang, Ross A. Soo
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 111
Background ALK and ROS1 gene rearrangements are distinct molecular subsets of non-small-cell lung cancer (NSCLC), and they are strong predictive biomarkers of response to ALK/ROS1 inhibitors, such as crizotinib. Thus, it is clinically important to de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27c141851db57f5ebbd24406dd5d572d
https://pubmed.ncbi.nlm.nih.gov/28838404
https://pubmed.ncbi.nlm.nih.gov/28838404
Autor:
Ross A. Soo, Sun Min Lim, Byoung Chul Cho, Gu Li, Thomas Perez, Frank Polichit, Ekaterina Pestova, Liang Shel, Won Young Park, Yoon Jin Cha, Yan Chin Tai, Hyun Chang, Hyo Sup Shim, Hye Ryun Kim
Publikováno v:
Journal of Thoracic Oncology. 12:S505-S506
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6bd6fbc35e854d5d86b42d9a75456a3
https://doi.org/10.1016/j.jtho.2016.11.613
https://doi.org/10.1016/j.jtho.2016.11.613
Autor:
Beth Blondin, Stephen K. Van Den Eeden, Adam J. Koch, Huixin Fei, Ekaterina Pestova, Ying Zhang, Svetlana Sitailo
Publikováno v:
Cancer Research. 77:4730-4730
Background: Overdiagnosis and overtreatment of men with lower-risk Prostate Cancer (PCa) is a concern due to co-morbidities and healthcare costs. Maximizing patient quality of life while recognizing early signs of aggressive disease is essential. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8689711b5c89d8ee1381c8bed3cc9f3
https://doi.org/10.1158/1538-7445.am2017-4730
https://doi.org/10.1158/1538-7445.am2017-4730
Autor:
George Vasmatzis, Leonid A. Sitailo, Steven N. Hart, Kevin C. Halling, Gregory J. Gores, Mitesh J. Borad, Lewis R. Roberts, Emily G. Barr Fritcher, John Schulz, Fergus J. Couch, Lizhi Zhang, Rondell P. Graham, Benjamin R. Kipp, Robert R. McWilliams, Stephen J. Murphy, Ekaterina Pestova
Publikováno v:
Human pathology. 45(8)
Patients with cholangiocarcinoma often present with locally advanced or metastatic disease. There is a need for effective therapeutic strategies for advanced stage cholangiocarcinoma. Recently, FGFR2 translocations have been identified as a potential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd94e8e7a88b8420e4ad8efbb3d15861
https://pubmed.ncbi.nlm.nih.gov/25466307
https://pubmed.ncbi.nlm.nih.gov/25466307
Publikováno v:
Journal of Antimicrobial Chemotherapy. 45:583-590
The in vitro activity of the novel 8-methoxyquinolone, moxifloxacin, against Streptococcus pneumoniae was evaluated, and the intracellular targets of this agent were studied. Analysis of mutant strains selected with moxifloxacin demonstrated that fir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4872635fa154e3801d3585cedf55368
https://doi.org/10.1093/jac/45.5.583
https://doi.org/10.1093/jac/45.5.583